Announcements Trials
Browse Landscape

Status

Completed 18Recruiting 12Active not recruiting 4Unknown 3Withdrawn 2Terminated 2Suspended 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Breast 3Tumor-Agnostic 2Gastrointestinal 2Plasma cell 1Other hematologic neoplasm 1Gynecologic 1Genitourinary 1

Conditions

Colorectal Neoplasms 2Breast Neoplasms 2Stomach Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Pain 1Neoplasms, Plasma Cell 1Neoplasms 1Gastrointestinal Neoplasms 1Cholangiocarcinoma 1

Interventions

Fluorouracil 51Oxaliplatin 49Gemcitabine 47Leucovorin 41Capecitabine 35Bevacizumab 29Irinotecan 25Cisplatin 22Radiotherapy 18Radiosurgery 18pembrolizumab 16Nivolumab 16Cetuximab 15Taxes 14Sorafenib 14Paclitaxel 13Biopsy 13Surgical Procedures, Operative 12Drug Therapy 11atezolizumab 10Radiation 10Albumin-Bound Paclitaxel 10lenvatinib 9durvalumab 9Magnetic Resonance Spectroscopy 9Folfox protocol 9Cyclophosphamide 9130-nm albumin-bound paclitaxel 9spartalizumab 8Chemotherapy, Adjuvant 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Interviews as Topic × Gastrointestinal × Clear all
NCT03563352 2020-12-14

Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer

University of Southern California

Withdrawn
BreastGastrointestinalGenitourinary

Breast Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT01016028 2016-05-03

Chemotherapy-Induced Peripheral Neuropathy Survey

M.D. Anderson Cancer Center

Withdrawn
BreastGastrointestinalPlasma cell

Breast Neoplasms, Neoplasms, Pain, Colorectal Neoplasms, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡